Expiration Date: July 1, 2019
Title: Hospital Medicine – Infectious Diseases: MRSA; C. difficile; Skin and Soft Tissue Infections; Septic Shock
Faculty: Vandana Y. Bhide, M.D., F.A.C.P., F.A.A.P., A.B.I.H.M., Ganesan Murali, M.D., and Kendal Williams, M.D., M.P.H.
Original Release Date: July 1, 2016 Review Date: July 1, 2017 Expiration Date: July 1, 2019
TOPIC 1: Challenging Infections: MRSA and C. difficile.
Upon completion of this session, the participant should be able to: COMP
- Assess and apply appropriate treatment strategies for different types of methicillin resistant staph aureus infections.
- Employ rational use and relate the precautions of newer antibiotics when treating resistant bacteria.
- Distinguish Guideline based treatment of Clostridium difficile infections.
TOPIC 2: Overview of the Inpatient Management of Skin and Soft Tissue Infections.
Upon completion of this session, the participant should be able to: EBM, COMP
- Review the clinical presentation and categorization of common skin and soft tissue infections.
- Differentiate common non-infectious conditions that can mimic skin and soft tissue infections.
- Based on evidence from the CDC and standard of care publications, recognize and incorporate the changing epidemiology and resistance patterns impacting skin and soft tissue infections into therapeutic plans.
- Recognize the types of drug-associated rashes and formulate an effective treatment plan for each.
TOPIC 3: Septic Shock.
Upon completion of this session, the participant should be able to: GL, COMP
- Define shock and differentiate the various types of shock.
- Develop and apply the concept of sepsis management bundles.
- Formulate and manage the early resuscitation of septic shock, vasopressor use and monitoring.
- Specify the current controversies in management of septic shock based on SCCM/Survival Sepsis Campaign Guidelines.
- The receipt for any incentive-associated purchase will designate the value of the gift card separately from the cost of the learning activity.
- This incentive may have implications on your tax reporting obligations. Any reimbursed amount must be declared as personal income for tax purposes.